PACIRA PHARMACEUTICALS INC's ticker is and the CUSIP is 695127AB6. A total of 12 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,994,000 | -49.7% | 2,127,000 | -46.9% | 0.02% | -37.0% |
| Q2 2016 | $5,947,000 | +14767.5% | 4,003,000 | +17304.3% | 0.03% | – |
| Q3 2015 | $40,000 | +263.6% | 23,000 | +475.0% | 0.00% | – |
| Q2 2015 | $11,000 | -99.7% | 4,000 | -99.6% | 0.00% | -100.0% |
| Q1 2015 | $3,570,000 | +502.0% | 1,000,000 | +502.4% | 0.02% | +566.7% |
| Q4 2014 | $593,000 | – | 166,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EQUITEC SPECIALISTS, LLC | 3,000,000 | $4,524,000 | 1.31% |
| Myriad Asset Management Ltd. | 10,000,000 | $14,880,000 | 0.95% |
| WHITEBOX ADVISORS LLC | 11,350,000 | $17,117,000 | 0.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,743,000 | $32,797,000 | 0.49% |
| MIZUHO SECURITIES USA LLC | 3,500,000 | $5,275,000 | 0.44% |
| Verition Fund Management LLC | 1,160,000 | $1,755,000 | 0.19% |
| CSS LLC/IL | 1,500,000 | $2,245,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 982,000 | $1,473,000 | 0.05% |
| Citadel Advisors | 30,050,000 | $45,358,000 | 0.05% |
| LAZARD ASSET MANAGEMENT LLC | 9,000,000 | $13,618,000 | 0.03% |